- Home
- THFF vs AVBP Comparison
THFF vs AVBP Comparison
Compare THFF & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- AVBP
- Stock Information
- Founded
- THFF 1984
- AVBP 2021
- Country
- THFF United States
- AVBP United States
- Employees
- THFF N/A
- AVBP N/A
- Industry
- THFF Major Banks
- AVBP
- Sector
- THFF Finance
- AVBP
- Exchange
- THFF Nasdaq
- AVBP NYSE
- Market Cap
- THFF 578.4M
- AVBP 617.4M
- IPO Year
- THFF N/A
- AVBP 2024
- Fundamental
- Price
- THFF $53.19
- AVBP $19.10
- Analyst Decision
- THFF Buy
- AVBP Strong Buy
- Analyst Count
- THFF 2
- AVBP 6
- Target Price
- THFF $56.50
- AVBP $39.00
- AVG Volume (30 Days)
- THFF 58.0K
- AVBP 153.2K
- Earning Date
- THFF 04-22-2025
- AVBP 05-12-2025
- Dividend Yield
- THFF 3.88%
- AVBP N/A
- EPS Growth
- THFF N/A
- AVBP N/A
- EPS
- THFF 4.63
- AVBP N/A
- Revenue
- THFF $215,577,000.00
- AVBP N/A
- Revenue This Year
- THFF $27.69
- AVBP $63.13
- Revenue Next Year
- THFF $2.89
- AVBP N/A
- P/E Ratio
- THFF $11.36
- AVBP N/A
- Revenue Growth
- THFF 9.26
- AVBP N/A
- 52 Week Low
- THFF $34.60
- AVBP $15.47
- 52 Week High
- THFF $53.60
- AVBP $36.37
- Technical
- Relative Strength Index (RSI)
- THFF 69.05
- AVBP 42.78
- Support Level
- THFF $49.75
- AVBP $18.86
- Resistance Level
- THFF $51.64
- AVBP $21.21
- Average True Range (ATR)
- THFF 1.42
- AVBP 1.20
- MACD
- THFF 0.51
- AVBP -0.09
- Stochastic Oscillator
- THFF 97.71
- AVBP 8.97
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.